| Patient | Lili Boulanger |
|---|---|
| Date of birth | 1893-08-21 |
| Identifiers | MRN HR-ET025-SYN-TD; SSN (made up) 000-25-7731 |
| Document date | 1915-01-28 |
| Author | Odile Marchetti-Rowe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Results of colonoscopy, MR enterography, and tuberculosis tests. [S]
Ms. Boulanger returns nine days after presenting with four months of right lower abdominal cramping, loose stools up to six times a day and at night, evening fevers, and loss of 6 kg. The ileocolonoscopy five days ago showed deep longitudinal ulcers over the last 15 cm of the terminal ileum and patchy ulcers in the ascending and transverse colon with normal mucosa between and a spared rectum (SES-CD 14). The biopsies show chronic active ileitis and colitis with crypt distortion and a few small non-caseating granulomas; the acid-fast stain and TB PCR are negative and the mycobacterial culture is pending. MR enterography two days ago shows 18 cm of inflamed terminal ileum without stricture, fistula, abscess, or necrotic nodes. The interferon-gamma release assay is negative and the chest X-ray normal. Stool tests for Clostridioides difficile, bacterial pathogens, and parasites are negative, and celiac serology is negative. The pregnancy test is negative. She has five or six loose stools a day with cramping and fatigue (Harvey-Bradshaw Index 11). She met Dr. Nwankwo-Delacroix this morning and chose a treatment with him. She has a concert of her choral works in late March and asked whether she could still perform. [S]
| Element | Detail |
|---|---|
| Endoscopy | Ileocolonic ulceration, SES-CD 14; rectum spared |
| Histology | Chronic active ileocolitis with small non-caseating granulomas; AFB and TB PCR negative; culture pending |
| Imaging | 18 cm of inflamed terminal ileum; no stricture, fistula, or abscess |
| Infection screen | IGRA negative; chest X-ray normal; HBsAg and anti-HBc negative, anti-HBs below 10; HCV and HIV negative; measles and varicella IgG positive |
| Activity | Harvey-Bradshaw Index 11 (moderate) |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue and evening fevers to 37.6 °C; weight steady this week |
| Gastrointestinal | Positive | Five or six loose stools a day, one at night; right lower quadrant cramps; no blood |
| Eyes | Negative | No red or painful eyes |
| Musculoskeletal | Negative | No joint pain or swelling |
| Integumentary | Negative | No tender red nodules on the shins |
| Psychiatric | Positive | Low and anxious about the concert; PHQ-9 8, GAD-7 9 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth up to every 6 hours as needed for abdominal pain, no more than 3000 mg a day; no nonsteroidal anti-inflammatory drugs | One or two tablets up to every 6 hours as needed | Oral route | 1914-12-15 | active | S |
| Prednisone 20 mg oral tablet: 40 mg by mouth each morning, reduced by 5 mg each week over eight weeks, as a bridge until risankizumab takes effect | 40 mg each morning, tapering by 5 mg weekly | Oral route | 1915-01-28 to 1915-03-24 | completed | S |
| Cholecalciferol (vitamin D3) 1889 units oral tablet, one tablet by mouth once daily | One tablet once daily | Oral route | 1915-01-28 | active | S |
| Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet by mouth once daily with food while on prednisone | One tablet daily with food | Oral route | 1915-01-28 to 1915-03-24 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1915-01-28 | Body height | 160 | cm | S |
| 1915-01-28 | Body weight | 44.8 | kg | S |
| 1915-01-28 | Body mass index (BMI) [Ratio] | 17.5 | kg/m2 | S |
| 1915-01-28 | Systolic blood pressure | 102 | mm[Hg] | S |
| 1915-01-28 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1915-01-28 | Heart rate | 92 | /min | S |
| 1915-01-28 | Respiratory rate | 16 | /min | S |
| 1915-01-28 | Body temperature | 37.4 | Cel | S |
| 1915-01-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1915-01-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 1915-01-28 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 1915-01-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | <=33 U/L | Normal | S |
| 1915-01-28 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 20 | U/L | <=32 U/L | Normal | S |
| 1915-01-28 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.4 | mg/dL | <=1.2 mg/dL | Normal | S |
| 1915-01-28 | DXA Lumbar spine [Z-score] Bone density | -1.4 | {Z-score} | A Z-score of -2.0 or below is below the expected range for age | Normal | S |
| 1915-01-28 | DXA Femur [Z-score] Bone density | -1.1 | {Z-score} | A Z-score of -2.0 or below is below the expected range for age | Normal | S |
Vital signs recorded on 1915-01-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin and tired; BMI 17.5 |
| Mouth | Two small aphthous ulcers inside the lower lip |
| Abdomen | Tender in the right lower quadrant with fullness but no discrete mass; no guarding |
| Perianal | No fistula, abscess, or skin tags |
| Skin | No erythema nodosum |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Crohn disease of the terminal ileum and colon (ileocolitis), Montreal A2 L3 B1 without perianal disease, moderate to severe: deep ileal ulcers over 15 cm and patchy colonic ulcers, SES-CD 14, Harvey-Bradshaw Index 11; intestinal tuberculosis excluded by negative interferon-gamma release assay, normal chest X-ray, and biopsies negative for acid-fast bacilli, TB PCR, and mycobacterial culture; synthetic modern diagnosis linked to her documented chronic intestinal illness, whose historical diagnosis is not settled | active | confirmed | K50.80 | S — Synthetic diagnosis confirmed within the modern episode; her historical illness is documented (D), but whether it was intestinal tuberculosis or Crohn disease remains a retrospective interpretation (R) and is disputed. |
| Four months of crampy right lower abdominal pain, loose stools up to six times a day including at night, low-grade evening fevers, and loss of 6 kg; inflammatory markers raised; colonoscopy and small-bowel imaging booked | resolved | confirmed | R19.7 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis; the documented symptoms of early 1915 are echoed (D). |
| Iron deficiency anemia from chronic intestinal blood loss and poor absorption (hemoglobin 10.6 g/dL, MCV 76, ferritin 9) | active | confirmed | D50.0 | S — Synthetic finding at presentation; corrected by intravenous iron. |
| Moderate protein-calorie malnutrition: BMI 17.6 after losing 6 kg (12 percent of body weight) in four months; albumin 3.3 g/dL | active | confirmed | E44.0 | S — Synthetic nutritional status at presentation; resolved with treatment and dietitian support. |
| Vitamin D deficiency (25-hydroxyvitamin D 18 ng/mL) | active | confirmed | E55.9 | S — Synthetic finding at presentation. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Ileocolonoscopy with biopsies | At diagnosis | Up to date | Five days ago: SES-CD 14; chronic active ileocolitis with small non-caseating granulomas |
| Imaging | Cross-sectional imaging of the small bowel (MR enterography) | At diagnosis, for extent and complications | Up to date | Two days ago: 18 cm of inflamed terminal ileum; no stricture, fistula, or abscess |
| Laboratory | Exclusion of intestinal tuberculosis: biopsy acid-fast stain, TB PCR, and mycobacterial culture | At diagnosis, before immunosuppression | Up to date | Acid-fast stain and TB PCR negative; culture pending, to be reviewed at six weeks |
| Laboratory | Latent tuberculosis screen (interferon-gamma release assay) and chest X-ray | Before steroids or a biologic | Up to date | IGRA negative; chest X-ray normal |
| Laboratory | Hepatitis B, hepatitis C, and HIV screening | Before immunosuppression | Up to date | HBsAg and anti-HBc negative; anti-HBs below 10 mIU/mL after an infant series; HCV antibody and HIV negative |
| Laboratory | Stool tests for Clostridioides difficile and enteric pathogens; celiac serology | At diagnosis | Up to date | All negative |
| Laboratory | Liver enzymes and bilirubin before risankizumab | At baseline | Completed today | ALT 18, AST 20, bilirubin 0.4 |
| Medication safety | Vaccines before immunosuppression | Before starting, when possible | Completed today | PCV20, recombinant zoster dose 1, and a hepatitis B booster today; immune to measles and varicella, so no live vaccine is needed and treatment need not wait |
| Laboratory | Hepatitis B antibody after the booster | One to two months after the dose | Due | At the next visit |
| Imaging | Bone density (DXA) | At diagnosis with risk factors (low weight, vitamin D deficiency, corticosteroids) | Completed today | Lumbar spine Z-score -1.4, femoral neck -1.1: within the expected range for age |
| Survey | Depression and anxiety screen (PHQ-9 and GAD-7) | At diagnosis and at least yearly | Completed today | PHQ-9 8 and GAD-7 9, mild; offered the IBD psychology service |
| Referral | Gastroenterology (inflammatory bowel disease) | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Self-management | Dietitian and nutrition plan | At diagnosis with weight loss | Completed today | Seen today; supplements started |
| Self-management | Contraception and pregnancy planning | At diagnosis for women of reproductive age | Completed today | Not sexually active; pregnancy test negative; counseled to avoid pregnancy while the disease is active and to plan any pregnancy in remission |
| Self-management | Smoking status | Every visit | Completed today | Never smoker |
Goal progress:
Immunizations given today: Pneumococcal conjugate vaccine PCV20, before immunosuppression; Recombinant zoster vaccine, dose 1 of 2, before immunosuppression; Hepatitis B vaccine, adult booster dose (infant series, anti-HBs below 10 mIU/mL) [S]
Guideline basis: ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol 2025;120(6):1225-1264 (2025); AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology 2021 (2021); ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. J Crohns Colitis 2024;18(10):1531-1555 (2024); ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2026 (2026); ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol 2025;120:1447-1473 (2025); SKYRIZI (risankizumab-rzaa): prescribing information (Crohn disease dosing; hepatotoxicity monitoring; tuberculosis evaluation; immunizations) (2026)
Follow-up: First risankizumab infusion and intravenous iron in five days. Review at the second infusion, in four weeks. Next scheduled visit 1915-03-02: review at week 4 of risankizumab, on the day of the second induction infusion. [S]